We provide patients ethical access to medicines not available in their countries, so called Unlicensed Medicines. This business is based on the principle "patient first", and is often referred to as “named patient” or “compassionate use” programs.
There are several reasons why a medicine is not available to a patient in a country, including medicines:
Our global footprint and combined expertise in regulatory, quality and logistics, helps you access the medicine that you need when you need it.
clinical trials supported each year
years of knowhow and experience